Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)
Jun 06
Swedish (OMX) Life Sciences Industry Analysis
UpdatedJun 16, 2024
DataAggregated Company Financials
Companies12
- 7D-0.2%
- 3M13.2%
- 1Y7.4%
- YTD14.0%
Last week, the Life Sciences industry hasn't moved much but AddLife is up 6.8% in that time. The past year has been better, since the industry has gained 7.4% in that time. Looking forward, earnings are forecast to grow by 48% annually.
Industry Valuation and Performance
Has the Swedish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 16 Jun 2024 | kr43.1b | kr16.3b | -kr1,188,686,510.00 | 58.1x | -36.2x | 2.6x |
| Tue, 14 May 2024 | kr40.1b | kr16.3b | -kr1,157,635,671.00 | 36x | -34.6x | 2.5x |
| Thu, 11 Apr 2024 | kr39.2b | kr16.0b | -kr1,122,792,213.00 | 35.6x | -35x | 2.5x |
| Sat, 09 Mar 2024 | kr39.7b | kr16.0b | -kr1,123,139,210.00 | 40.2x | -35.3x | 2.5x |
| Mon, 05 Feb 2024 | kr39.0b | kr15.8b | -kr1,473,823,683.00 | 55.6x | -26.5x | 2.5x |
| Wed, 03 Jan 2024 | kr37.9b | kr15.5b | -kr1,393,723,683.00 | 44.8x | -27.2x | 2.5x |
| Fri, 01 Dec 2023 | kr34.6b | kr15.4b | -kr1,395,872,683.00 | 40.2x | -24.8x | 2.2x |
| Sun, 29 Oct 2023 | kr27.1b | kr15.4b | -kr1,255,923,711.00 | 32x | -21.6x | 1.8x |
| Tue, 26 Sep 2023 | kr27.3b | kr15.1b | -kr1,134,516,711.00 | 38.8x | -24.1x | 1.8x |
| Thu, 24 Aug 2023 | kr29.9b | kr15.0b | -kr1,155,464,038.00 | 41.8x | -25.9x | 2x |
| Sat, 22 Jul 2023 | kr32.2b | kr14.9b | -kr239,671,038.00 | 41.6x | -134.3x | 2.2x |
| Mon, 19 Jun 2023 | kr40.1b | kr14.6b | -kr172,476,038.00 | 38.7x | -232.5x | 2.7x |
| Wed, 17 May 2023 | kr38.6b | kr14.6b | -kr205,506,792.00 | 38.6x | -187.6x | 2.6x |
| Fri, 14 Apr 2023 | kr33.3b | kr14.6b | -kr57,449,459.00 | 33.3x | -579.3x | 2.3x |
| Sun, 12 Mar 2023 | kr34.8b | kr14.6b | -kr57,185,459.00 | 30.3x | -609x | 2.4x |
| Tue, 07 Feb 2023 | kr42.9b | kr14.3b | kr827.3m | 40x | 51.9x | 3x |
| Thu, 05 Jan 2023 | kr39.3b | kr14.1b | kr944.3m | 40.5x | 41.7x | 2.8x |
| Sat, 03 Dec 2022 | kr38.8b | kr14.1b | kr944.3m | 42.4x | 41.1x | 2.7x |
| Mon, 31 Oct 2022 | kr33.9b | kr13.8b | kr743.0m | 55.2x | 45.7x | 2.5x |
| Wed, 28 Sep 2022 | kr32.7b | kr13.5b | kr750.9m | 47.8x | 43.6x | 2.4x |
| Fri, 26 Aug 2022 | kr40.1b | kr13.5b | kr746.2m | 55.6x | 53.7x | 3x |
| Sun, 24 Jul 2022 | kr45.5b | kr13.1b | kr662.4m | 43.9x | 68.7x | 3.5x |
| Tue, 21 Jun 2022 | kr43.6b | kr13.2b | kr753.4m | 38.9x | 57.9x | 3.3x |
| Thu, 19 May 2022 | kr52.5b | kr12.9b | kr749.4m | 46.9x | 70.1x | 4.1x |
| Sat, 16 Apr 2022 | kr65.4b | kr11.8b | kr732.3m | 54.3x | 89.3x | 5.5x |
| Mon, 14 Mar 2022 | kr55.5b | kr11.8b | kr745.4m | 46.5x | 74.4x | 4.7x |
| Wed, 09 Feb 2022 | kr55.4b | kr11.3b | kr749.1m | 47.4x | 73.9x | 4.9x |
| Fri, 07 Jan 2022 | kr82.4b | kr10.8b | kr786.3m | 57.2x | 104.8x | 7.6x |
| Sun, 05 Dec 2021 | kr79.7b | kr10.8b | kr787.8m | 50.4x | 101.1x | 7.4x |
| Tue, 02 Nov 2021 | kr98.6b | kr10.5b | kr892.5m | 56.9x | 110.4x | 9.3x |
| Thu, 30 Sep 2021 | kr90.3b | kr9.9b | kr853.6m | 51.2x | 105.8x | 9.2x |
| Sat, 28 Aug 2021 | kr98.7b | kr9.9b | kr853.6m | 57.4x | 115.6x | 10x |
| Sun, 04 Jul 2021 | kr76.7b | kr9.9b | kr853.6m | 49.2x | 89.8x | 7.8x |
Price to Earnings Ratio
89.8x
Current Industry PE
- Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.0x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 18% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | -2.15% | |
| Healthcare | -2.20% | |
| Life Sciences | -0.21% | |
| Clinical Research and Equipment | -0.21% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALIF B AddLife | kr124.50 | 6.8% +kr962.7m | -4.2% | PE194.5x | |
| PRO Promimic | kr34.80 | 3.3% +kr20.5m | 33.8% | PS15.4x | |
| ATANA Attana | kr0.087 | 4.8% +kr1.6m | -45.6% | PS4.8x | |
| CLINE B Cline Scientific | kr0.09 | 1.1% +kr45.0k | -75.0% | PS1x |
